Last updated: July 17, 2026

Application No. 18/406,937

DINUCLEAR GOLD(I) COMPLEXES FOR TREATING CANCER

Non-Final OA

Filed

Jan 08, 2024

Examiner

MOORE, SUSANNA

Art Unit

1624

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

King Fahd University of Petroleum and Minerals

OA Round

1 (Non-Final)

Interview Optional

— +31.6% interview lift. Examiner has a relatively high allowance rate (68%); +31.6% interview lift. A written response may suffice.

Based on 1249 resolved cases, 2023–2026

Examiner Intelligence

MOORE, SUSANNA View full profile →

Grants 68% — above average

Career Allowance Rate

849 granted / 1249 resolved

+8.0% vs TC avg

Strong +32% interview lift

Without

With

+31.6%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

69 currently pending

Career history

1317

Total Applications

across all art units

Statute-Specific Performance

§101

0.4%

-39.6% vs TC avg

§103

24.1%

-15.9% vs TC avg

§102

13.4%

-26.6% vs TC avg

§112

21.1%

-18.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1249 resolved cases

Prosecution Timeline

Jan 08, 2024

Application Filed

Mar 02, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/009,481

Patent 12679851

METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF

3y 7m to grant Granted Jul 14, 2026

17/755,858

Patent 12673944

COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

4y 1m to grant Granted Jul 07, 2026

17/912,301

Patent 12673970

NEUROACTIVE STEROIDS AND THEIR METHODS OF USE

3y 9m to grant Granted Jul 07, 2026

17/435,830

Patent 12667573

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE

4y 10m to grant Granted Jun 30, 2026

18/359,709

Patent 12655157

NOVEL ACC INHIBITORS

2y 10m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

68%

Grant Probability

99%

With Interview (+31.6%)

2y 10m (~4m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1249 resolved cases by this examiner. Grant probability derived from career allowance rate.